Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Danske Bank $2 billion notes offering
The investment-grade notes are due 2025 and 2028
Equinix $1.2 billion green bonds offering
We advised Equinix on the investment-grade debt offering
Grupo Aval spinoff of BAC Holding International
We advised Grupo Aval on the unregistered spinoff of a 75% equity stake in its indirect subsidiary
Incora comprehensive recapitalization transaction
We advised an ad hoc group of secured noteholders on the recapitalization
SPX FLOW $500 million senior notes offering
The high-yield notes were issued in connection with Lone Star’s financing for the acquisition of SPX FLOW
Workday $3 billion senior notes offering
The investment-grade notes are due 2027, 2029 and 2032
YUM! Brands $1 billion senior notes offering
The high-yield notes are due 2032
Bank of America C$350 million reopening of fixed-to-floating-rate notes
The investment-grade notes are due 2028
Gates Industrial $87.1 million secondary offering
The SEC-registered equity offering consists of 5.75 million shares
Evergreen- and Brookfield-led consortium $16 billion acquisition of Nielsen
We are advising Brookfield on the transaction